Home › Von Hippel-Lindau Disease › Texas
Von Hippel-Lindau Disease clinical trials in Texas
3 studies for Von Hippel-Lindau Disease are looking for participants at sites in Texas.
Belzutifan/MK-6482 for the Treatment of Advanced Pheochromocytoma/Paraganglioma (PPGL), Pancreatic Neuroendocrine Tumor (pNET), Von Hippel-Lindau (VHL) Disease-Associated Tumors, Advanced Gastrointestinal Stromal Tumor (wt GIST), or Solid Tumors With HIF-2α Related Genetic Alterations (MK-6482-015)
- University of Texas MD Anderson Cancer Center ( Site 0112), Houston
RecruitingPhase 2
Ages 12 and older · All sexes · Updated Sep 25, 2026 · NCT04924075Extension Study for Participants in Studies That Include Belzutifan (MK-6482-043/LITESPARK-043)
- START San Antonio ( Site 0104), San Antonio
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 23, 2026 · NCT07405164Data Collection Protocol for Patients With Von Hippel Lindau Disease
- M D Anderson Cancer Center, Houston
RecruitingObservational study
Ages 18 and older · All sexes · Updated Jun 26, 2026 · NCT05955014From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.